Literature DB >> 16619042

Apoptotic DNA fragmentation factor maintains chromosome stability in a P53-independent manner.

B Yan1, H Wang, H Wang, D Zhuo, F Li, T Kon, M Dewhirst, C-Y Li.   

Abstract

DNA fragmentation factor (DFF)/caspase-activated DNase (CAD) is responsible for DNA fragmentation, a hallmark event during apoptosis. Although DNA fragmentation is an evolutionarily conserved process across species, its biological function is not clearly understood. In this study, we constructed cell lines expressing a mutant ICAD (inhibitor of CAD) protein that is resistant to caspase cleavage and therefore constantly binds to DFF/CAD and inhibits DNA fragmentation. We found that irradiation of these cells led to increased chromosome aberrations and aneuploidy when compared with their parental controls. The increased chromosome instability is observed irrespective of cellular P53 status, suggesting that the effect of DFF/CAD is independent of P53. Inhibition of apoptotic DNA fragmentation resulted in increased clonogenic survival of irradiated cells and a delay in removal of cells with DNA damages induced by radiation, an effect similar to that in cells with p53 mutations. Consistent with DFF/CAD's effect on clonogenic survival, tumors established from cells deficient in DNA fragmentation showed enhanced growth in nude mice. Therefore, our results suggest that DFF/CAD plays an important and P53-independent role in maintaining chromosome stability and suppressing tumor development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16619042     DOI: 10.1038/sj.onc.1209535

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Apoptosis-inducing activities of Halopteris scoparia L. Sauvageau (Brown algae) on cancer cells and its biosafety and antioxidant properties.

Authors:  Adem Güner; Ayşe Nalbantsoy; Atakan Sukatar; Nefise Ülkü Karabay Yavaşoğlu
Journal:  Cytotechnology       Date:  2019-04-09       Impact factor: 2.058

2.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

3.  An intrinsic DFF40/CAD endonuclease deficiency impairs oligonucleosomal DNA hydrolysis during caspase-dependent cell death: a common trait in human glioblastoma cells.

Authors:  María Sánchez-Osuna; Laura Martínez-Escardó; Carla Granados-Colomina; Fina Martínez-Soler; Sònia Pascual-Guiral; Victoria Iglesias-Guimarais; Roser Velasco; Gerard Plans; Noemi Vidal; Avelina Tortosa; Carlos Barcia; Jordi Bruna; Victor J Yuste
Journal:  Neuro Oncol       Date:  2016-01-10       Impact factor: 12.300

4.  Sensitization of breast cancer cells to doxorubicin via stable cell line generation and overexpression of DFF40.

Authors:  Fatemeh Bagheri; Shahrokh Safarian; Mohamadreza Baghaban Eslaminejad; Nader Sheibani
Journal:  Biochem Cell Biol       Date:  2015-09-15       Impact factor: 3.626

5.  Next-generation sequencing of apoptotic DNA breakpoints reveals association with actively transcribed genes and gene translocations.

Authors:  Melissa J Fullwood; Joanne Lee; Lifang Lin; Guoliang Li; Mikael Huss; Patrick Ng; Wing-Kin Sung; Shirish Shenolikar
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

6.  ICAD deficiency in human colon cancer and predisposition to colon tumorigenesis: linkage to apoptosis resistance and genomic instability.

Authors:  Youssef Errami; Hassan Brim; Karine Oumouna-Benachour; Mustapha Oumouna; Amarjit S Naura; Hogyoung Kim; Jihang Ju; Christian J Davis; Jong G Kim; Hassan Ashktorab; Kenneth Fallon; Ming Xu; Jianhua Zhang; Luis Del Valle; A Hamid Boulares
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

7.  Regulation of mammalian horizontal gene transfer by apoptotic DNA fragmentation.

Authors:  B Yan; H Wang; F Li; C-Y Li
Journal:  Br J Cancer       Date:  2006-12-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.